Immunohistochemistry scores for GRP94 were significantly higher in high grade gliomas (Grades III-IV/GBM) compared with lower grade tumors, astrocytic hyperplasia, or normal brain (Figure 8A, B). This evidence concerns the gene HSP90B1 and central nervous system cancer.